Below is a list of cancer diagnoses CancerCare® currently supports through its co-payment assistance foundation. The status of the fund for each diagnosis will change periodically throughout the year from open to closed based upon available funding.
For a complete list of cancer diagnoses supported through CancerCare®’s comprehensive support services outside of the co-payment assistance foundation, click here.
CoPay Funding Status
| Disease State | Status | Insurance Type | FPL % |
| Acute Lymphoblastic Leukemia | Open | Federal/Medicare | 500% |
| Acute Myeloid Leukemia | Closed | Federal/Medicare | 500% |
| Breast | Closed | ANY | 500% |
| Metastatic Breast | Closed | Federal/Medicare | 500% |
| Bladder | Closed | Federal/Medicare | 500% |
| Cancer Related Pain Management | Closed | Federal/Medicare | 500% |
| Cervical | Closed | ANY | 500% |
| Chronic Lymphocytic Leukemia | Open | Federal/Medicare | 500% |
| Chronic Myeloid Leukemia | Closed | Federal/Medicare | 500% |
| Metastatic Colorectal | Closed | Federal/Medicare | 500% |
| Gastric | Closed | ANY | 500% |
| Glioblastoma | Closed | ANY | 500% |
| Head and Neck | Closed | ANY | 500% |
| Hepatocellular Carcinoma (HCC) | Closed | Federal/Medicare | 500% |
| Melanoma | Closed | Federal/Medicare | 500% |
| Merkel Cell Carcinoma | Closed | Federal/Medicare | 500% |
| Multiple Myeloma | Closed | Federal/Medicare | 500% |
|
Myeloproliferative Neoplasms
|
Open | Federal/Medicare | 500% |
| Non-Hodgkin's Lymphoma (NHL) | Closed | Federal/Medicare | 500% |
| Non-Small Cell Lung | Closed | Federal/Medicare | 500% |
| Small Cell Lung | Closed | Federal/Medicare | 500% |
| Ovarian | Closed | Federal/Medicare | 500% |
| Pancreatic Cancer (Does not include Pancreatic Neuroendocrine Tumors PNET) | Open | ANY | 500% |
| Metastatic Prostate | Closed | Federal/Medicare | 500% |
| Prostate | Closed | Federal/Medicare | 500% |
| Renal Cell | Closed | Federal/Medicare | 500% |
| Soft Tissue Sarcoma | Closed | ANY | 500% |
| Metastatic Differentiated Thyroid Cancer | Open | Federal/Medicare | 500% |
| Metastatic Pheochromocytoma and Paraganglioma | Open | Federal/Medicare | 500% |
| Metastatic Skin Cancer - Non Melanoma | Closed | Federal/Medicare | 500% |
